Hodge; James W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hodge; James W..The latest application filed is for "combination of histone deacetylase inhibitor and immunotherapy".

Company Profile

1.9.9

Hodge; James W. - Kensington MD
Hodge; James W. - Gaithersberg MD
Hodge; James W. - Gaithersburg MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combination Of Histone Deacetylase Inhibitor And Immunotherapy App 20220040160 - Hodge; James W. ; et al.	2022-02-10
Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis App 20200140567 - Schlom; Jeffrey ; et al.	2020-05-07
Combination Of Histone Deacetylase Inhibitor And Immunotherapy App 20190183870 - Hodge; James W. ; et al.	2019-06-20
Immunogenic Modulation By Endocrine Deprivation Therapy Improves Sensitivity Of Tumor Cells To Immune Mediated Lysis App 20170306042 - Schlom; Jeffrey ; et al.	2017-10-26
System for treating and preventing breast cancer Grant 8,933,041 - Panicali , et al. January 13, 2	2015-01-13
Custom vectors for treating and preventing pancreatic cancer Grant 8,901,093 - Panicali , et al. December 2, 2	2014-12-02
Method of enhancing a targeted immune response against tumors Grant 7,662,395 - Schlom , et al. February 16, 2	2010-02-16
Method Of Enhancing A Targeted Immune Response Against Tumors App 20080279887 - Schlom; Jeffrey ; et al.	2008-11-13
Custom Vectors for Treating and Preventing Pancreatic Cancer App 20080166367 - Panicali; Dennis L. ; et al.	2008-07-10
Method of enhancing a targeted immune response against tumors Grant 7,368,116 - Schlom , et al. May 6, 2	2008-05-06
System for treating and preventing breast cancer App 20070110718 - Panicali; Dennis L. ; et al.	2007-05-17
Enhanced immune response to an antigen by a composition of a recominant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule App 20050186180 - Schlom, Jeffrey ; et al.	2005-08-25
Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule Grant 6,893,869 - Schlom , et al. May 17, 2	2005-05-17
Enhanced Immune Response To An Antigen By A Composition Of A Recombinant Virus Expressing The Antigen With A Recombinant Virus Expressing An Immunostimulatory Molecule App 20050063993 - Schlom, Jeffrey ; et al.	2005-03-24
Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule Grant 6,548,068 - Schlom , et al. April 15, 2	2003-04-15
Enhanced immune response to an antigen by a composition of a recombinant virus expressing the antigen with a recombinant virus expressing an immunostimulatory molecule Grant 6,045,802 - Schlom , et al. April 4, 2	2000-04-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.